Clene (NASDAQ: CLNN) , together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead d ...

Somewhere between recycled meme coins and overhyped layer-2s projects, a new batch of projects is quietly stealing the ...

In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis ...

In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...

As the dynamic world of cryptocurrencies continues to evolve and mature, savvy investors are looking for the moonshot potential to capitalise on high ROI in ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

The crypto market is buzzing with exciting developments, and presale crypto tokens are taking center stage.  Among the most ...

Crypto presales are heating up, with Lightchain AI and BlockDAG drawing serious attention from market watchers. Lightchain AI ...